跳至主要内容
临床试验/JPRN-UMIN000031505
JPRN-UMIN000031505招募中未知

Randomized-controlled trial to evaluate the efficacy of Lusutrombopag on EVL-AS therapy in thrombocytopenic patients - Randomized-controlled trial to evaluate the efficacy of Lusutrombopag on EVL-AS therapy in thrombocytopenic patients

Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University,0 个研究点目标入组 40 人开始时间: 2018年2月27日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients were excluded if they had a history of hypersensitivity of lusutrombopag, or if they were pregnant, or they had a history of arterial or venous thrombosis with on-going risk factors for thrombosis, or had a severe liver damages (Child-Pugh score C), or had a severe renal dysfunction, or took anticoagulant or antiplatelet drug.

研究者

发起方
Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University,

相似试验